Study of an experimental herbal medicine plus standard care for pneumonia
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether adding an experimental herbal medicine (NRICM102) to standard antibiotics can help adults hospitalized with community-acquired pneumonia recover faster. It is a phase 2 study, meaning the treatment is still being tested for safety and effectiveness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You have been diagnosed with pneumonia (confirmed by chest X-ray) and have at least two symptoms like cough, sputum, fever, or abnormal breathing sounds.
- You need to stay in the hospital and receive antibiotics through an IV.
- You can take oral medication.
- You have not taken antibiotics within 72 hours before the study screening (except routine ones given after admission).
- You have not taken oral traditional Chinese medicine within 7 days before hospital admission.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how traditional Chinese medicine (TCM) can help adults aged 60 and older who have community-acquired pneumonia (a lung infection caught outside a hospital). It aims to see if TCM can improve recovery and overall well-being.
This trial tests a new medication called OPT101 for people hospitalized with pneumonia and sepsis (a severe infection that affects the whole body). The drug may help reduce inflammation and improve oxygen levels. The study focuses on those who need extra oxygen but are not yet on a breathing machine.
This trial tests a way to give antibiotics directly to the lungs (inhaled or nebulized) for people hospitalized with moderate to severe pneumonia. The goal is to see if this local treatment works better than standard antibiotics alone and helps you recover faster.
This trial compares different antibiotic strategies for children with pneumonia who are being treated as outpatients. The goal is to find the best approach to treat the infection and help your child recover.
This trial studies whether a more detailed genetic test of lung fluids can find the exact cause of pneumonia in people whose first treatment isn't working, and help doctors choose a more effective treatment sooner.
This trial tests an herbal medicine called NRICM102 for people with chronic cough and long-term lung diseases like asthma or COPD. It aims to see if the medicine is safe and helps improve symptoms.
Hear when a new Antibiotic Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.